abstract |
The present invention generally relates to unit dosage forms of naproxen and H 2 -receptor antagonists, comprising an immediate-release formalution of naproxen; an immediate-release formulation of an H 2 -receptor antagonist, and a delayed-burst release formulation of an H 2 -receptor antagonist. |